Advertisement
Screener

ILLUMINA, INC. (ILMN) Overview

ILLUMINA, INC. (ILMN) Overview

  • 30 Mar 2026: Period ending 28 Jun 2026; Estimate (m); Actual 1.35; Beat / miss (m).
  • 29 Dec 2025: Period ending 29 Mar 2026; Estimate (m); Actual 0.87; Beat / miss (m).
  • 30 Jun 2025: Period ending 28 Sept 2025; Estimate (m); Actual 0.98; Beat / miss (m).
  • 31 Mar 2025: Period ending 29 Jun 2025; Estimate (m); Actual 1.49; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$108.72$132.07$160.43$194.89$236.75$287.592025-11-062026-11-06$66.79$97.05$141.04$204.97$297.87$432.872021-11-082026-11-06$66.79$101.29$153.64$233.03$353.44$536.072016-11-072026-11-06$13.34$27.92$58.44$122.34$256.09$536.072006-11-062026-11-06$0.84$3.05$11.09$40.40$147.17$536.072000-07-282026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$213.05
Previous close
$272.00
Change
-$58.95
Change (%)
-21.67%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ILMN
+107.38%
S&P 500
(m)

1 year

ILMN
+196.07%
S&P 500
(m)

3 years

ILMN
+103.68%
S&P 500
(m)

5 years

ILMN
-32.07%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

28 Jun 2026 ○ Estimate (m) ● Actual 1.35

0.740.971.211.441.6730 Mar 2025: estimate (m); actual 0.8230 Mar 2025(m)29 Jun 2025: estimate (m); actual 1.4929 Jun 2025(m)28 Sept 2025: estimate (m); actual 0.9828 Sept 2025(m)29 Mar 2026: estimate (m); actual 0.8729 Mar 2026(m)28 Jun 2026: estimate (m); actual 1.3528 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
30 Mar 202628 Jun 2026(m)1.35(m)(m)
29 Dec 202529 Mar 2026(m)0.87(m)(m)
30 Jun 202528 Sept 2025(m)0.98(m)(m)
31 Mar 202529 Jun 2025(m)1.49(m)(m)
30 Dec 202430 Mar 2025(m)0.82(m)(m)

28 Dec 2025 ○ Estimate (m) ● Actual 5.45

-28.08-19.65-11.22-2.805.632 Jan 2022: estimate (m); actual 5.042 Jan 2022(m)1 Jan 2023: estimate (m); actual -28.001 Jan 2023(m)31 Dec 2023: estimate (m); actual -7.3431 Dec 2023(m)29 Dec 2024: estimate (m); actual -7.6929 Dec 2024(m)28 Dec 2025: estimate (m); actual 5.4528 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
30 Dec 202428 Dec 2025(m)5.45(m)(m)
1 Jan 202429 Dec 2024(m)-7.69(m)(m)
2 Jan 202331 Dec 2023(m)-7.34(m)(m)
3 Jan 20221 Jan 2023(m)-28.00(m)(m)
4 Jan 20212 Jan 2022(m)5.04(m)(m)

Revenue vs. Earnings

USD

28 Jun 2026 ■ Revenue 1.16B ■ Earnings 0.21B — Profit margin 17.86%

-0.14B11.3%0.34B17.5%0.82B23.6%1.30B29.8%28 Sept 2025: revenue 1.08B; earnings 0.15B; profit margin 13.84%28 Sept 202528 Dec 2025: revenue 1.16B*; earnings 0.33B; profit margin 28.82%*; Revenue: Annual amount − nine-month amount; Earnings: Reported; period 2025-09-29 to 2025-12-28; USD.28 Dec 202529 Mar 2026: revenue 1.09B; earnings 0.13B; profit margin 12.28%29 Mar 202628 Jun 2026: revenue 1.16B; earnings 0.21B; profit margin 17.86%28 Jun 2026

28 Dec 2025 ■ Revenue 4.34B ■ Earnings 0.85B — Profit margin 19.57%

-5.48B-97.1%-1.77B-57.9%1.95B-18.6%5.66B20.6%1 Jan 2023: revenue 4.58B; earnings -4.40B; profit margin -96.07%1 Jan 202331 Dec 2023: revenue 4.50B; earnings -1.16B; profit margin -25.78%31 Dec 202329 Dec 2024: revenue 4.37B; earnings -1.22B; profit margin -27.97%29 Dec 202428 Dec 2025: revenue 4.34B; earnings 0.85B; profit margin 19.57%28 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$213.05(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$213.05High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning ILMN

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 28 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$824.00M
Profit margin
18.34%
Return on assets · 12 month
12.94%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
4.03M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
9.92%*
Total return · month
26.17%*
Total return · quarter
50.19%*
Total return · half year
131.15%*
Total return · year to date
107.38%*
Total return · 1 year
196.07%*
Total return · 3 years
103.68%*
Total return · 5 years
-32.07%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$4.49B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ILLUMINA, INC. Overview

View more →

(m)

(m)

SEC CIK
1110803
Industry (SIC)
3826 Laboratory Analytical Instruments
Country of operation
United States
Business address
5200 ILLUMINA WAY, SAN DIEGO, California, 92122, United States
Fiscal year end
0103
Phone
8582024500

Similar stocks

Stock NameCountryMarket CapPE Ratio
WATERS CORP /DE/ (WAT)United States$42.297B224.28
AGILENT TECHNOLOGIES, INC. (A)United States$48.720B27.14
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
REVVITY, INC. (RVTY)United States$16.814B53.44
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53